Latest Regulatory Approval News

Cyprium Metals has made significant strides in its phased restart of the Nifty Copper Complex, targeting a final investment decision in Q3 2025, while consolidating 100% ownership of the Paterson Exploration Project after IGO's exit.

Cokal Limited has secured a strategic US$15 million debt facility to support infrastructure and coal production at its Indonesian BBM mine, while cautiously navigating weak market conditions with minimal production and resumed domestic shipments.

Resources & Energy Group Limited (REZ) reports strong progress in gold production at East Menzies with two successful gold pours and a $1.1 million capital raise, while divesting its Mount Mackenzie asset to sharpen focus on Western Australia.

Admiralty Resources NL reports steady progress at its Mariposa Iron Ore Project in Chile, securing a major sales contract and advancing critical infrastructure during Q2 2025.

Pacific Lime and Cement Limited has made significant strides in Papua New Guinea, rebranding and advancing key projects while initiating commercial quicklime shipments to Western Australia. The company’s robust cash position and community agreements set the stage for upcoming construction milestones.

Pilot Energy reports significant progress in transitioning the Cliff Head Oil Field to a carbon storage facility, alongside a major upgrade in WA-481P gas and oil prospective resources and a $6.8 million capital raise.

Marvel Gold Limited is progressing its acquisition of the Hanang Gold Project in Tanzania with key regulatory approvals underway, while navigating delays in Mali that impact the sale of its Tabakorole and Yanfolila gold assets.

Duxton Farms has announced a strategic merger with four private agricultural companies, aiming to significantly expand its asset base and diversify its commodity exposure. The move positions the company for enhanced market presence and long-term growth.

Optiscan Imaging Ltd has launched its first in-human breast cancer study and unveiled a new veterinary imaging device, while securing a key US collaboration to support FDA submissions.

Investor Centre Limited is progressing a key capital raising while its subsidiary Pulse Markets grows wholesale trading operations, signaling strategic momentum despite modest cash outflows.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.

Invion Limited has secured a $20,000 grant to support its anogenital cancer trial and progressed its skin cancer study with promising early results, while raising approximately $1 million through a Loyalty Option Entitlement Offer.